At this AEI event, experts discussed whether CER is likely to reduce costs without sacrificing the quality of care.

This paper analyses the impact of comparative effectiveness research (CER) on health and medical care spending interpreting CER to shift the demand for some treatments at the expense of others.

If a new comparative effectiveness research agency is allowed to use different--or inferior--scientific standards than those imposed on the private sector, the government will be the only voice in CER.

Does increased use of technology in itself cause more rapid growth in US health care expenditures as a share of the economy, compared to other countries?

As co-authors of Why ObamaCare Is Wrong for America,we strongly recommend that the Affordable Care Act of 2010 should be repealed and replaced as soon as possible.

A bill in the House could tie your doctor's hands.

The FDA is restricting the speech of private drug firms. This may violate the First Amendment rights of drugs companies.